CRGX CARGO Therapeutics, Inc.: institutional ownership and insider trading
2 funds reported holding $39.2M of CARGO Therapeutics, Inc. in their latest 13F filings; in Q4 2025 funds net bought $0, with 0 new positions and 1 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
CRGX revenue and earnings
- Quarter ended Jun 30, 2025: revenue n/a, net income −$49.9M, EPS -1.04
- Quarter ended Mar 31, 2025: revenue n/a, net income −$84.5M, EPS -1.77
- Quarter ended Dec 31, 2024: revenue n/a, net income −$45.4M, EPS -0.95
- Quarter ended Sep 30, 2024: revenue n/a, net income −$41.9M, EPS -0.88
Largest institutional holders of CRGX
- Nextech Invest Ltd. — $38.1M
- Nuveen Asset Management, LLC — $1.09M
Recent CRGX insider trades
- Jul 2, 2025: Radhakrishnan Anup sold 1,632 shares ($6.82K)
- May 14, 2025: Radhakrishnan Anup sold 27,404 shares ($105K)
- Apr 3, 2025: Radhakrishnan Anup sold 1,629 shares ($6.52K)
5%+ owners
- TANG CAPITAL MANAGEMENT, LLC: 100.0% (Schedule 13D/A, filed Aug 21, 2025)
- Madison Avenue Partners LP: 9.1% (Schedule 13G/A, filed Aug 14, 2025)
- Cormorant Asset Management, LP: 7.3% (Schedule 13G, filed May 15, 2025)
Who owns the most CRGX stock?
The largest institutional holders of CARGO Therapeutics, Inc. in the latest 13F filings are Nextech Invest Ltd. ($38.1M), Nuveen Asset Management, LLC ($1.09M).
Are insiders buying or selling CRGX?
No open-market insider buys or sells of CARGO Therapeutics, Inc. were reported in the last 12 months.